Fundraising FoxBiotech Startups
11,051 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
enVVeno Medical Corporation develops tissue-based replacement venous valves to treat chronic venous insufficiency in the deep venous system of the leg. The company is pursuing FDA approval for its next-generation enVVe System, a minimally invasive, catheter-based replacement valve designed for patients with severe chronic venous disease.
0 investors
0 investors
Hapten Sciences develops early-stage pharmaceutical products focused on dermatological health, with its lead candidate PDC-APB in clinical development as a preventive immunotherapy for contact dermatitis caused by exposure to poisonous plants. The company targets healthcare providers and individuals affected by urushiol-related skin conditions.
0 investors
0 investors
Harrow Health develops and sells branded ophthalmic medications and medical devices for conditions including dry eye disease, age-related macular degeneration, glaucoma, and cataracts through direct sales to U.S. eyecare professionals, and operates a pharmaceutical compounding pharmacy serving ophthalmologists with customized formulations.
0 investors
0 investors
HRGN (Harvard Apparatus Regenerative Technology, operating Biostage) is a clinical-stage regenerative medicine company developing treatments for esophageal conditions, including a therapy for esophageal atresia, a congenital defect affecting newborns. Its lead candidate entered a Phase 1 clinical trial in 10 patients at sites including Mayo Clinic and the University of Michigan.
0 investors
Harvest Connect operates a wellness ecosystem of plant-based medicine brands, including Graceleaf CBD/CBN blends, Aspen Tree natural wellness products, CBD Store & More retail locations, and EntheoTech Health, which researches natural and psychedelic compounds for treating Traumatic Brain Injury. It serves consumers seeking mental wellness and calm through cannabinoid products, with retail operations in the southeastern US and Washington DC.
0 investors
HavaH Therapeutics develops T+Ai, a subcutaneous extended-release pellet combining testosterone and anastrozole, aimed at preventing and treating hormone receptor positive breast cancer, including ductal carcinoma in situ (DCIS) and ER+ disease. The clinical-stage company targets the intra-mammary hormonal balance to slow tumor growth and reduce the need for surgery.
0 investors
0 investors
HDL Therapeutics is a commercial-stage biotechnology company with an FDA-approved therapy that reduces coronary atheroma in a rare cardiovascular disease. The company develops therapies targeting cardiovascular, neurodegenerative, autoimmune, viral, and peripheral vascular diseases.
0 investors
0 investors
0 investors
0 investors
0 investors
HealthŌme combines insurance with health navigation services to improve how patients access, finance, and receive precision healthcare.
0 investors
0 investors
0 investors
0 investors
0 investors
Helicase Venture is a life sciences investment firm focused on biotech and healthcare innovation. The firm invests in and supports the development of pharmaceutical and biotechnology companies.
0 investors
0 investors